The Global Nuclear Medicine Software Market is projected to grow from USD 980.5 million in 2025 to USD 1.8 billion by 2032, with a compound annual growth rate (CAGR) of 9.1%. Key drivers include the rising prevalence of chronic diseases like cancer, increased demand for advanced diagnostic solutions, and advancements in technologies like artificial intelligence (AI) which enhance image analysis and operational efficiency. However, high implementation costs remain a barrier to market growth, particularly for small healthcare facilities. Trends such as the shift towards personalized medicine, cloud-based solutions, and theranostics are also shaping the market. Recent developments include new AI-powered software from companies like GE Healthcare and Royal Philips aimed at improving diagnostic accuracy and workflow efficiency.
Thu, 04 Sep 2025 13:18:45 GMT | GlobeNewswire